UBS AM’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-113,386
| Closed | -$464K | – | 2871 |
|
|
2024
Q2 | $464K | Buy |
113,386
+45,914
| +68% | +$188K | ﹤0.01% | 2643 |
|
|
2024
Q1 | $1.06M | Buy |
67,472
+4,296
| +7% | +$67.7K | ﹤0.01% | 1980 |
|
|
2023
Q4 | $957K | Sell |
63,176
-185,938
| -75% | -$2.82M | ﹤0.01% | 2045 |
|
|
2023
Q3 | $5M | Buy |
249,114
+20,777
| +9% | +$417K | ﹤0.01% | 1205 |
|
|
2023
Q2 | $3.93M | Hold |
228,337
| – | – | ﹤0.01% | 1344 |
|
|
2023
Q1 | $3.93M | Sell |
228,337
-11,671
| -5% | -$201K | ﹤0.01% | 1344 |
|
|
2022
Q4 | $4.83M | Buy |
240,008
+14,112
| +6% | +$284K | ﹤0.01% | 1185 |
|
|
2022
Q3 | $4.89M | Buy |
225,896
+81,401
| +56% | +$1.76M | ﹤0.01% | 1211 |
|
|
2022
Q2 | $4.06M | Buy |
144,495
+14,724
| +11% | +$414K | ﹤0.01% | 1285 |
|
|
2022
Q1 | $5.99M | Sell |
129,771
-7,813
| -6% | -$360K | ﹤0.01% | 1280 |
|
|
2021
Q4 | $11.6M | Buy |
137,584
+117,283
| +578% | +$9.86M | ﹤0.01% | 1068 |
|
|
2021
Q3 | $1.35M | Buy |
20,301
+198
| +1% | +$13.2K | ﹤0.01% | 2014 |
|
|
2021
Q2 | $1.07M | Buy |
20,103
+2,503
| +14% | +$133K | ﹤0.01% | 2169 |
|
|
2021
Q1 | $764K | Buy |
17,600
+6,100
| +53% | +$265K | ﹤0.01% | 2207 |
|
|
2020
Q4 | $597K | Buy |
+11,500
| New | +$597K | ﹤0.01% | 2233 |
|